Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients

Lourdes Mengual, Maria Frantzi^*, Marika Mokou, Mercedes Ingelmo-Torres, Michiel Vlaming, Axel S. Merseburger, Marie C. Roesch, Zoran Culig, Antonio Alcaraz, Antonia Vlahou, Harald Mischak, Antoine G. Van der Heijden